Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on ...

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...

Alcon shares fell after the Swiss eye-care giant trimmed its full-year guidance due to President Trump’s trade tariffs.

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

Traders eyed earnings from big-name retailers Lowe's and Target. Palantir and Intel fell as the tech selloff deepened.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Gain insights from Alcon Inc.'s Q2 2025 earnings call, including new product launches, strategic acquisitions, market trends, and updated financial guidance.

The company forecasts a full-year gross tariff impact of around $100 million, up from $80 million expected previously ...

Shares of Alcon fell after the company posted a lower second-quarter profit and cut its full-year sales outlook, saying it expected a full-year tariff impact of $100 million. The stock was down 9.1% ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the ...

Global eye care leader Alcon has announced it will acquire Lake Forest-based Staar Surgical, a manufacturer of implantable ...